Interestingly, we found that surufatinib treatment inhibited tumor growth, overexpression of PTPN9 exhibited higher inhibit effect, whereas knockout of PTPN9 markedly exacerbated tumor growth (Fig. 1E, F). This evidence concerns the gene PTPN9 and neoplasm.